Your session is about to expire
← Back to Search
Transfusion Strategies for Anemia (EToF Trial)
EToF Trial Summary
This trial is testing whether restrictive transfusions (at Hb<7g/dL) are as effective as liberal transfusions (at Hb<9g/dL) in reducing fatigue and improving activity levels in hospitalized patients with anemia.
EToF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEToF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.EToF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot attend follow-up visits after leaving the hospital.I have sickle cell anemia.I refuse to receive blood transfusions.I am only receiving treatment to ease cancer symptoms.I am 18 years old or older.
- Group 1: Liberal Transfusion Arm
- Group 2: Restrictive Transfusion Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment searching for new participants at present?
"Affirmative. Data on clinicaltrials.gov affirms that this study, which was first publicized in February of 2022, is still actively searching for participants. There are 748 available slots at a single medical facility."
What is the overall participation rate for this experiment?
"Affirmative. The online record on clinicaltrials.gov confirms that this research has been luring participants since February 1st 2022 and was most recently updated May 16th 2022. Altogether, 748 subjects are expected to join the study from a single trial centre."
Share this study with friends
Copy Link
Messenger